Microbial Testing: Mould and Bacteria in Cannabis

Why Microbial Contamination Is a Critical Quality Issue

• Medical cannabis patients frequently have compromised immune systems due to chemotherapy, HIV, organ transplantation or long-term steroid use; microbial contamination that would be harmless to a healthy adult can cause life-threatening infections in this population.
• Cannabis flower has a large surface area and high moisture content at harvest, creating ideal conditions for bacterial and fungal growth during drying, curing and storage.
• Aspergillus fumigatus, a filamentous fungus that produces heat-stable mycotoxins, is the most dangerous microbial contaminant in cannabis; inhalation has caused fatal invasive aspergillosis in immunocompromised patients.
• Total aerobic count (TAC), total yeast and mould count (TYMC), E. coli, Salmonella and Aspergillus species are the mandatory microbial tests required for pharmaceutical cannabis release in the UK and EU.

Microbial testing is the patient safety backstop in pharmaceutical cannabis quality assurance; it directly prevents potentially fatal infections in the vulnerable patients who most need medical cannabis.

Key Microbial Contaminants in Cannabis

• Aspergillus species (A. fumigatus, A. flavus, A. niger, A. terreus) are the most clinically significant fungal contaminants; all four must be absent per gram in pharmaceutical cannabis.
• Botrytis cinerea (grey mould) is the most common post-harvest fungal disease in cannabis; visual inspection during curing and controlled humidity management are the primary preventive measures.
• E. coli and Salmonella are absence-tested in all pharmaceutical cannabis batches; contamination from fertilisers, water or processing personnel is the most common source.
• Total aerobic count limits of ≤10⁵ CFU/g (flower for inhalation) and total yeast/mould limits of ≤10⁴ CFU/g align with European Pharmacopoeia specifications for inhaled herbal medicinal products.

The specific microbial limits applied to pharmaceutical cannabis are calibrated to the vulnerability of the patient population and the direct-to-lung exposure route of inhalation administration.

Testing Methods and Laboratory Requirements

• Pharmacopoeial microbial testing methods (Ph. Eur. 2.6.12 for TAMC/TYMC, 2.6.13 for pathogens) are the required analytical procedures for pharmaceutical cannabis release.
• Real-time PCR (polymerase chain reaction) methods provide faster results than traditional culture methods and are now widely used in cannabis testing for Aspergillus and E. coli detection.
• Cannabis matrix inhibition — caused by cannabinoids and terpenes that have inherent antimicrobial properties — must be controlled through validated neutralisation and dilution procedures.
• Environmental monitoring swabs from cultivation and processing areas are tested routinely alongside finished product; a clean facility environment is the best predictor of clean product.

Pharmacopoeial microbial testing in an ISO 17025-accredited laboratory is the only acceptable analytical framework for pharmaceutical cannabis quality release; shortcuts in this area directly endanger patients.

Preventing Microbial Contamination in EU-GMP Facilities

• HVAC systems maintain positive pressure, HEPA filtration and controlled air exchange throughout EU-GMP cannabis facilities to prevent airborne microbial ingress.
• Personnel hygiene protocols including gowning procedures, hand sanitation and health screening are enforced to prevent human-origin contamination during cultivation and post-harvest processing.
• Water activity (aw) management during drying and curing is the most critical post-harvest control; cannabis flower with aw above 0.65 is at significant risk of mould development during storage.
• Validated decontamination methods including gamma irradiation and X-ray irradiation are used by some producers to reduce microbial counts in finished product while preserving cannabinoid and terpene integrity.

Prevention is always preferable to remediation in pharmaceutical cannabis; the combination of environmental controls, personnel discipline and validated post-harvest management makes contamination exceedance a rare event in well-run EU-GMP facilities.